IOLCP vs ORCHPHARMA: Stock Comparison

IOL Chemicals and Pharmaceuticals Limited vs Orchid Pharma Limited

Live data: 22 July 2026, 3:02 PM IST • Source: NSE and company filings

Orchid Pharma Limited is the larger company by market capitalisation. IOL Chemicals and Pharmaceuticals Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of IOL Chemicals and Pharmaceuticals Limited and Orchid Pharma Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, IOLCP is more favourable on 13 of 13 scored metrics and ORCHPHARMA on 0These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ORCHPHARMA is the larger company
₹5,072 Cr vs ₹4,363 Cr
P/E Ratio
IOLCP has a lower P/E
32.2x vs 253.09x
P/B Ratio
IOLCP has a lower P/B
2.46x vs 4.04x
EPS
IOLCP has higher earnings per share
₹4.69 vs ₹4.01
Dividend Yield
IOLCP has a higher dividend yield
0.64% vs 0%
Revenue Growth (TTM YoY)
IOLCP has faster revenue growth
17.4% vs -1.5%
EPS Growth (TTM YoY)
IOLCP has faster EPS growth
69.7% vs 0%
Qtr Sales Growth
IOLCP has stronger quarterly sales growth
17.4% vs 0.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricIOLCPORCHPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricIOLCPORCHPHARMA
Live Price₹148.41₹1,000.7
Day Change-1.72%-2.18%
Volume13.06 L82,380
52-Week High₹179.6₹1,119.8
52-Week Low₹67.19₹480
Distance from 52W High-17.37%-10.64%

Valuation

MetricIOLCPORCHPHARMA
Market Cap₹4,363 Cr₹5,072 Cr
P/E Ratio32.2x253.09x
P/B Ratio2.46x4.04x
EPS₹4.69₹4.01
Book Value₹61.24₹253.98
Dividend Yield0.64%0%

Growth

MetricIOLCPORCHPHARMA
Revenue Growth (TTM YoY)17.4%-1.5%
EPS Growth (TTM YoY)69.7%0%
Qtr Sales Growth17.4%0.05%
Qtr Profit Growth69.2%4.26%

Profitability & Leverage

MetricIOLCPORCHPHARMA
ROE8.38%2.12%
ROCE11.2%2.64%
Net Margin5.94%2.51%
Operating Margin11.6%5.07%
Debt to Equity0.08x0.28x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricIOLCPORCHPHARMA
Promoter Holding62.28% 4.8 pp69.84%
FII Holding4.87% 3.15 pp0.87% 0.3 pp
DII Holding0.43% 0.41 pp20.25% 0.86 pp
Public Holding32.42% 8.36 pp9.05% 0.55 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: IOL Chemicals and Pharmaceuticals Limited and Orchid Pharma Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.